Exploring how sex and gender affect lung disease
Official title: Mentoring in Patient Oriented Research in Lung Disease through a Sex and Gender Lens
Funded at Brigham and Women's Hospital · NIH-11004143 · Data updated 2026-11-12
This study is looking at how lung disease, like COPD, affects men and women differently, so we can better understand their unique risks, symptoms, and treatment responses, while also helping new researchers learn how to consider these differences in their work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | January 1, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $128,650 |
| NIH project number | 5K24HL171900-02 |
| Project ID | NIH-11004143 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with chronic obstructive pulmonary disease (COPD) who are interested in how their sex and gender may influence their condition.
✕Less likely to help
Patients with lung diseases unrelated to COPD or those who do not identify with the biological sex or gender constructs being studied may not benefit from this research.
What this research studies
This research investigates the differences in lung disease between males and females, focusing on how these differences impact risk, progression, symptoms, and treatment responses. By utilizing advanced data science techniques, the project aims to analyze genetic and biological factors that contribute to these disparities. The program also emphasizes mentoring new researchers in understanding and applying sex and gender considerations in their work, particularly in the context of chronic obstructive pulmonary disease (COPD). Through this approach, the research seeks to translate findings into practical clinical innovations that can improve patient care.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for lung diseases based on sex and gender differences.
How similar studies have gone: Previous research has shown promising results in understanding sex and gender differences in other health conditions, suggesting potential for success in this novel approach to lung disease.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Demeo, Dawn L — Brigham and Women's Hospital
- Study coordinator: Demeo, Dawn L
Related research
Other NIH-funded projects on the same topics.
-
Targeted therapies for glioblastoma in adults and kids
A large NIH program is exploring new brain cancer therapies, including drugs that reach the brain and work against glioblastoma in both children and adults.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large study will test whether taking rosuvastatin every day for a year can lower the chance of dangerous blood clots in people with cancer, without raising the risk of bleeding.
-
Preterm infant body composition and early-life health after NICU stay
This grant studies how body composition in very preterm babies relates to later brain development and risk of obesity or diabetes, with findings meant to improve care from NICU through early childhood.
-
Rapid Emergency Skills for Prehospital Optimization and Delivery (RESPOND) for Guatemala
A lightweight, AI-enabled prehospital training and triage program helps volunteer firefighters in Guatemala deliver faster, better care to trauma patients.
-
Rapid Emergency Skills for Prehospital Optimization and Notification in Guatemala
A mobile, AI-powered training and triage program helps volunteer emergency responders in Guatemala provide faster, safer trauma care and notify hospitals more quickly.
-
Understanding antibiotic allergy to improve care for patients
Scientists are testing new ideas to understand why some people develop severe allergic reactions to antibiotics and how to prevent or treat them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.